SCHEMBL5048552

SCHEMBL5048552

CCCCNC(=O)c1cc(-c2csc(COc3ccc(OC)cc3)n2)n(Cc2cccs2)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
ALDH1A1 P00352 6/20 0.49
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 3/20 0.40
HSP90AA1 P07900 1/20 0.40
AKR1B10 O60218 1/20 0.40
AKR1B1 P15121 1/20 0.40
KLKB1 P03952 1/20 0.40
KLK1 P06870 1/20 0.40
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPK1 P28482 2/20 0.39
ESR1 P03372 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5048731 0.90 ALDH1A1 (0.46) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5048600 0.89 NPC1 (0.50) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5048654 0.88 MAPT (0.50) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5048595 0.86 ALDH1A1 (0.49) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5040255 0.86 MAPT (0.49) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5047587 0.86 ALDH1A1 (0.60) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5043686 0.83 HPGD (0.42) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5047146 0.82 CDC25A (0.45) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5044942 0.80 HPGD (0.48) MAPTALDH1A1NPC1RAB9AL3MBTL1
SCHEMBL5048702 0.79 ALDH1A1 (0.47) MAPTALDH1A1NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed